ZBTB38 and prostate cancer: Mechanistically, our results indicated that PRKDC is an important interacting protein of ZBTB38, which could repress the tumor-suppressive function of ZBTB38. Knocking down PRKDC could significantly promote DKK1 expression to suppress the malignant progression of prostate cancer cells.